Annual Cash & Cash Equivalents
$128.03 M
-$265.61 M-67.48%
31 December 2023
Summary:
Centessa Pharmaceuticals annual cash & cash equivalents is currently $128.03 million, with the most recent change of -$265.61 million (-67.48%) on 31 December 2023. During the last 3 years, it has risen by +$120.80 million (+1671.55%). CNTA annual cash & cash equivalents is now -78.49% below its all-time high of $595.08 million, reached on 31 December 2021.CNTA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$395.03 M
+$267.65 M+210.14%
30 September 2024
Summary:
Centessa Pharmaceuticals quarterly cash and cash equivalents is currently $395.03 million, with the most recent change of +$267.65 million (+210.14%) on 30 September 2024. Over the past year, it has increased by +$223.53 million (+130.34%). CNTA quarterly cash and cash equivalents is now -35.64% below its all-time high of $613.76 million, reached on 30 June 2021.CNTA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -67.5% | +130.3% |
| 3 y3 years | +1671.5% | -31.8% |
| 5 y5 years | +1855.6% | - |
CNTA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -78.5% | +1671.5% | -33.6% | +234.2% |
| 5 y | 5 years | -78.5% | +1855.6% | -35.6% | +234.2% |
| alltime | all time | -78.5% | >+9999.0% | -35.6% | +234.2% |
Centessa Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $395.03 M(+210.1%) |
| June 2024 | - | $127.37 M(+7.7%) |
| Mar 2024 | - | $118.22 M(-7.7%) |
| Dec 2023 | $128.03 M(-67.5%) | $128.03 M(-25.3%) |
| Sept 2023 | - | $171.50 M(+18.1%) |
| June 2023 | - | $145.22 M(-44.1%) |
| Mar 2023 | - | $259.99 M(-34.0%) |
| Dec 2022 | $393.64 M(-33.9%) | $393.64 M(-11.5%) |
| Sept 2022 | - | $444.84 M(-8.1%) |
| June 2022 | - | $484.16 M(-11.1%) |
| Mar 2022 | - | $544.47 M(-8.5%) |
| Dec 2021 | $595.08 M | $595.08 M(+2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $578.82 M(-5.7%) |
| June 2021 | - | $613.76 M(+105.5%) |
| Mar 2021 | - | $298.61 M |
| Dec 2020 | $7.23 M(-38.4%) | - |
| June 2020 | $11.73 M(+79.2%) | - |
| June 2019 | $6.55 M(-57.9%) | - |
| June 2018 | $15.56 M(+147.2%) | - |
| June 2017 | $6.29 M(+89.3%) | - |
| June 2016 | $3.32 M(-31.5%) | - |
| June 2015 | $4.85 M(>+9900.0%) | - |
| May 2015 | $400.00(-99.3%) | - |
| May 2014 | $55.30 K | - |
FAQ
- What is Centessa Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Centessa Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Centessa Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of CNTA is $128.03 M
What is the all time high annual cash & cash equivalents for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual cash & cash equivalents is $595.08 M
What is Centessa Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, CNTA annual cash & cash equivalents has changed by -$265.61 M (-67.48%)
What is Centessa Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CNTA is $395.03 M
What is the all time high quarterly cash and cash equivalents for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly cash and cash equivalents is $613.76 M
What is Centessa Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, CNTA quarterly cash and cash equivalents has changed by +$223.53 M (+130.34%)